Stephen P Squinto
CIK 1231954 · Head of Research and Dev · last filed 2022-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SWTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
352 KNOTTER DRIVE
CHESHIRE, CT 06410
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 6,317,959 | $46.99 | $296.88M | $3.35M | 8 | 2022-05-20 |
| CMPX | Director | — | $0.75 | — | $0 | 1 | 2022-02-23 |
| CMMB | Director | 11,984 | $1.04 | $12.5K | $0 | 1 | 2021-04-21 |
| PASG | Head of Research and Dev | — | $3.31 | — | $0 | 1 | 2020-03-02 |
| BOLD | Director | — | $2.41 | — | $0 | 2 | 2017-10-10 |
Recent Filings · Page 5 of 9
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-06 | — | Exer (M) | +13,000 | $0 | |
| 2012-01-30 | — | Sell (S) | −3,667 | -$273.2K | |
| 2012-01-11 | — | Sell (S) | −562 | -$42.1K | |
| 2011-10-25 | — | Mixed | +1,250 | -$3.03M | |
| 2011-07-27 | — | Mixed | −669 | -$1.36M | |
| 2011-07-12 | — | Sell (S) | −502 | -$25.1K | |
| 2011-03-04 | — | Mixed | — | -$392.6K | |
| 2011-02-23 | — | Mixed | −280 | -$738.4K | |
| 2011-02-04 | — | Grant (A) | +7,000 | $0 | |
| 2011-01-28 | — | Sell (S) | −1,330 | -$112.7K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.